|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,110 GBX | -0.46% |
|
-2.10% | +14.25% |
| May. 17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
| May. 16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
May 7 (Reuters) -
* THE OXFORD-ASTRAZENECA COVID VACCINE IS BEING WITHDRAWN WORLDWIDE- THE TELEGRAPH
* THE OXFORD-ASTRAZENECA COVID VACCINE IS BEING WITHDRAWN WORLDWIDE- THE TELEGRAPH Source text: https://bit.ly/4dy1N9I Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +14.25% | 239B | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B | |
| -0.52% | 162B |
ASTRAZENECA PLC 
